The Case for Genetic Screening in Senior Living

Genetics can tell a senior living community where to look before symptoms ever appear.

Integrated Senior Foundation has launched a genetic screening program across its communities, built around personalized, proactive care and the early detection of age-related conditions. The premise is straightforward: read the signals earlier. Genetic markers can offer insight into conditions that shape later life, including cardiovascular disease, diabetes, and neurological disorders, and identifying a predisposition early gives care teams room to intervene in ways that protect quality of life.

The program's first focus is the APOE gene. According to the National Institute on Aging, APOE is the strongest known genetic risk factor for late-onset Alzheimer's: the ε4 form raises risk and is linked to earlier onset, and carrying two copies raises it further [1]. Just as important, risk is not destiny. Many people who carry ε4 never develop the disease, which is precisely why the screening is treated as information rather than a verdict [1]. For residents who carry elevated risk but do not yet need memory care, that information lets ISF build targeted brain health programs well before decline would otherwise be visible.

Genetic data is most useful in context. Beyond screening, ISF communities continuously capture activity levels, vital signs, and dietary habits, all integrated into the resident health record. Combined with genetic insight, that fuller picture lets care teams design interventions for early cognitive change and other Alzheimer's risk factors, helping residents stay healthier and independent for longer.

"Connecting the dots between individual resident health metrics and community programs is key," said Bryan Ziebart, founder and CEO of Integrated Senior Foundation. "By understanding each resident's genetic predispositions, activity patterns, and sleep quality, Insight Living can create customized programs that support overall well-being, promoting healthier aging in the community."

Participation is voluntary, results are private, and resident data is handled under the same consent and governance standards that guide every ISF program. The genetic work is also one input into a deliberately deep approach to resident data, where many measurements per person, gathered over time, give a single result its meaning. Researchers call that depth deep phenotyping, and it is what turns a screening into a foundation for precise, personal care.

"Partnering with leading academic institutions, we're excited to be at the forefront of integrating data and personalized care into senior healthcare," said Yasaman Fatapour, PhD, who leads clinical data initiatives. "This collaboration enables us to advance research in senior care and apply cutting-edge science to enhance our residents' well-being."

The program is the front end of a wider plan. ISF intends to expand resident screening to include complimentary blood work, allergy testing, and sleep quality assessments. Knowing earlier, and acting on what is known, is how a community moves care from reactive to genuinely preventive.